News Image

BrainsWay Receives FDA Clearance for Accelerated Deep TMS Protocol for Non-Invasive Treatment of Major Depressive Disorder (MDD)

Provided By GlobeNewswire

Last update: Sep 16, 2025

Clinical data shows that BrainsWay’s new accelerated stimulation protocol is comparable to standard Deep TMS in depression score improvement, response and remission

Read more at globenewswire.com

BRAINSWAY LTD-ADR

NASDAQ:BWAY (10/23/2025, 8:00:02 PM)

16.63

+0.47 (+2.91%)



Find more stocks in the Stock Screener

Follow ChartMill for more